Share Name Share Symbol Market Type Share ISIN Share Description
Allergan Plc LSE:0Y7T London Ordinary Share IE00BY9D5467 ALLERGAN ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 154.21 0.00 0.00 0.00 0.00 0.00 163 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

J.P. Morgan Securities LLC Allergan plc 38.5b

22/01/2020 11:34am

UK Regulatory (RNS & others)


Allergan (LSE:0Y7T)
Historical Stock Chart

1 Month : From Jan 2020 to Feb 2020

Click Here for more Allergan Charts.

TIDM0Y7T

RNS Number : 6046A

J.P. Morgan Securities LLC

22 January 2020

Ap27

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

   1.          KEY INFORMATION 
 
Name of exempt principal    J.P Morgan Securities LLC 
 trader 
Company dealt in            Allergan plc 
                            ========================= 
Class of relevant security  Ordinary Share 
 to which the dealings 
 being disclosed relate 
 (Note 1) 
                            ========================= 
Date of dealing             21 January 2020 
                            ========================= 
 
   2.          INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 
                                         Long               Short 
                             Number      (%)     Number       (%) 
                             =========  ======  ===========  ====== 
                                                 4,260,102 
(1) Relevant securities       5,204,199 1.58      1.30 
                             =================  =================== 
(2) Derivatives (other                           4,398,486 
 than options)                5,134,127 1.56      1.34 
                             =================  =================== 
(3) Options and agreements 
 to purchase/sell             1,020,839 0.31     705,539 0.21 
                             =================  =================== 
                              11,359,166         9,364,127 
Total                          3.45               2.85 
                             =================  =================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 
Class of relevant security:               Long                Short 
                             Number        (%)     Number         (%) 
                             =========    ======  ===========    ====== 
(1) Relevant securities 
                             ===================  ===================== 
(2) Derivatives (other 
 than options) 
                             ===================  ===================== 
(3) Options and agreements 
 to purchase/sell 
                             ===================  ===================== 
Total 
                             ===================  ===================== 
 
 

Ap28

   3.       DEALINGS (Note 3) 
   (a)      Purchases and sales 
 
 Purchase/sale         Number of relevant securities       Price per unit 
                                                              (Note 4) 
  Purchases                      20                      192.0400 USD 
                                  2                       192.3750 USD 
                                  4                       192.4125 USD 
                                  1                       192.4300 USD 
                                  1                       192.4400 USD 
                                  1                       192.4800 USD 
                                  2                       192.4950 USD 
                                  1                       192.5000 USD 
                                  1                       192.5100 USD 
                                 14                       192.5186 USD 
                                 39                       192.5200 USD 
                                  1                       192.5300 USD 
                                  1                       192.5400 USD 
                                 45                       192.5476 USD 
                                  1                       192.5700 USD 
                               242,840                    192.5800 USD 
                                  1                       192.6000 USD 
                                  1                       192.6100 USD 
                                 18                       192.6289 USD 
                                 15                       192.6347 USD 
                                 25                       192.6380 USD 
                                  5                       192.6500 USD 
                                 91                       192.6800 USD 
                                 31                       192.6865 USD 
                                  1                       192.6900 USD 
                                 25                       192.7012 USD 
                                  2                       192.7050 USD 
                                 13                       192.7162 USD 
                                  2                       192.7200 USD 
                                 21                       192.7300 USD 
                                  2                       192.7500 USD 
                                 70                       192.7777 USD 
                                 24                       192.9271 USD 
 
     Sales                       40                       192.0400 USD 
                               39,199                     192.5800 USD 
                                 87                       192.6800 USD 
                ====================================  =================== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
   Product     Nature of transaction   Number of relevant   Price per 
    name,                                  securities          unit 
   e.g. CFD           (Note 5)              (Note 6)           (USD) 
                                                             (Note 4) 
Equity Swaps           Long                   20             192.0400 
                                             26,000           192.5800 
              ======================  ===================  =========== 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
  Product       Writing,       Number of      Exercise        Type,       Expiry          Option 
    name,       selling,       securities       price     e.g. American,   date     money paid/received 
  e.g. call    purchasing,      to which                     European                    per unit 
   option        varying       the option                      etc.                      (Note 4) 
                  etc.        relates (Note 
                                   7) 
 
 
   (ii)      Exercising 
 
 Product name,             Number of securities       Exercise price 
  e.g. call option                                     per unit (Note 
                                                       4) 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 3) 
 
 Nature of transaction         Details       Price per unit 
  (Note 7)                                    (if applicable) 
                                              (Note 4) 
 
 

Ap29

   4.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities

under any option referred to on this form or relating to the voting rights or future acquisition

or disposal of any relevant securities to which any derivative referred to on this form is

referenced. If none, this should be stated.

   Is a Supplemental Form 38.5(b) attached? (Note 8)                    YES 
 
Date of disclosure           22 January 2020 
Contact name                 Alwyn Basch 
                             ============================= 
Telephone number             020 7742 7407 
                             ============================= 
Name of offeree/offeror      Allergan plc 
 with which connected 
                             ============================= 
Nature of connection (Note   Financial Advisor to Allergan 
 9)                           plc 
                             ============================= 
 

Ap31

SUPPLEMENTAL FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)

 
   Product        Written        Number of      Exercise   Type, e.g.    Expiry 
    name,       or purchased      relevant        price     American,     date 
  e.g. call                      securities       (Note     European 
    option                        to which         2)         etc. 
                                 the option 
                                or derivative 
                                   relates 
 Put Option      Written          300,000       150.00     American    19JUN20 
 Put Option       Written          5,000         140.00     American    19JUN20 
 Put Option       Written         233,402        104.11     European    23JAN20 
 Put Option       Written         261,411        108.45     European    23JAN20 
 Put Option      Purchased        233,402        104.11     European    23JAN20 
 Put Option      Purchased        261,411        108.45     European    23JAN20 
 Call Option      Written          10,000        170.00     American    21FEB20 
 Call Option      Written         100,363        104.11     European    23JAN20 
 Call Option      Written         100,363        108.45     European    23JAN20 
 Call Option     Purchased         20,000        185.00     American    21FEB20 
 Call Option     Purchased          300          190.00     American    21FEB20 
 Call Option     Purchased        100,363        104.11     European    23JAN20 
 Call Option     Purchased        100,363        108.45     European    23JAN20 
              ==============  ===============  =========  ===========  ======== 
 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

   2.       For all prices and other monetary amounts, the currency must be stated. 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEFLLFLBFLXBBF

(END) Dow Jones Newswires

January 22, 2020 06:34 ET (11:34 GMT)

1 Year Allergan Chart

1 Year Allergan Chart

1 Month Allergan Chart

1 Month Allergan Chart
Your Recent History
LSE
0Y7T
Allergan
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200222 10:58:39